Norges Bank Alnylam Pharmaceuticals, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

49 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$143.31 - $247.0 $329 Million - $567 Million
2,296,781 New
2,296,781 $558 Million
Q4 2023

Feb 09, 2024
BUY
$151.41 - $196.57 $309 Million - $401 Million
2,039,798 New
2,039,798 $390 Million
Q3 2023

Nov 13, 2024
BUY
$170.77 - $211.65 $204 Million - $253 Million
1,193,566 New
1,193,566 $211 Million
Q3 2023

Nov 13, 2023
SELL
$170.77 - $211.65 $208 Million - $258 Million
-1,218,184 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$185.01 - $212.05 $295 Million - $338 Million
-1,593,427 Reduced 69.38%
703,354 $134 Million
Q2 2023

Aug 14, 2023
SELL
$185.01 - $212.05 $238 Million - $272 Million
-1,284,777 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$182.66 - $235.53 $278 Million - $358 Million
1,521,412 New
1,521,412 $305 Million
Q4 2022

Feb 14, 2023
BUY
$185.53 - $241.31 $188 Million - $244 Million
1,012,846 New
1,012,846 $241 Million
Q3 2022

Nov 13, 2023
BUY
$138.54 - $232.0 $169 Million - $283 Million
1,218,184 New
1,218,184 $244 Million
Q2 2022

Aug 14, 2023
BUY
$120.42 - $169.29 $155 Million - $217 Million
1,284,777 New
1,284,777 $187 Million
Q1 2022

May 12, 2023
BUY
$127.18 - $173.91 $35.9 Million - $49.1 Million
282,241 Added 27.87%
1,295,087 $211 Million
Q1 2022

May 09, 2022
SELL
$127.18 - $173.91 $161 Million - $221 Million
-1,269,191 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$159.56 - $209.29 $203 Million - $266 Million
1,269,191 New
1,269,191 $215 Million
Q3 2021

Nov 14, 2022
BUY
$169.75 - $207.73 $169 Million - $207 Million
994,888 New
994,888 $188 Million
Q3 2021

Nov 05, 2021
SELL
$169.75 - $207.73 $152 Million - $186 Million
-894,752 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$128.63 - $176.89 $115 Million - $158 Million
894,752 New
894,752 $152 Million
Q2 2021

Aug 10, 2021
SELL
$128.63 - $176.89 $124 Million - $170 Million
-962,304 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$126.83 - $175.69 $122 Million - $169 Million
962,304 New
962,304 $136 Million
Q1 2021

May 07, 2021
SELL
$126.83 - $175.69 $132 Million - $183 Million
-1,038,988 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$122.97 - $147.0 $128 Million - $153 Million
1,038,988 New
1,038,988 $135 Million
Q4 2020

Feb 10, 2021
SELL
$122.97 - $147.0 $128 Million - $153 Million
-1,040,349 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$121.19 - $165.49 $126 Million - $172 Million
1,040,349 New
1,040,349 $151 Million
Q3 2020

Nov 10, 2020
SELL
$121.19 - $165.49 $109 Million - $149 Million
-902,319 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$104.21 - $156.44 $94 Million - $141 Million
902,319 New
902,319 $134 Million
Q2 2020

Aug 07, 2020
SELL
$104.21 - $156.44 $103 Million - $155 Million
-987,765 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$93.12 - $133.99 $92 Million - $132 Million
987,765 New
987,765 $108 Million
Q1 2020

May 08, 2020
SELL
$93.12 - $133.99 $93.4 Million - $134 Million
-1,003,213 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$74.51 - $124.23 $74.7 Million - $125 Million
1,003,213 New
1,003,213 $116 Million
Q4 2019

Feb 12, 2020
SELL
$74.51 - $124.23 $83.8 Million - $140 Million
-1,124,222 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$70.9 - $87.82 $79.7 Million - $98.7 Million
1,124,222 New
1,124,222 $90.4 Million
Q3 2019

Nov 08, 2019
SELL
$70.9 - $87.82 $80.8 Million - $100 Million
-1,139,002 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$65.86 - $92.79 $75 Million - $106 Million
1,139,002 New
1,139,002 $82.6 Million
Q2 2019

Aug 09, 2019
SELL
$65.86 - $92.79 $75.5 Million - $106 Million
-1,146,869 Closed
0 $0
Q1 2019

May 11, 2020
SELL
$72.76 - $93.45 $10.6 Million - $13.6 Million
-145,507 Reduced 11.26%
1,146,869 $107 Million
Q4 2018

Mar 04, 2019
BUY
$62.67 - $88.33 $81 Million - $114 Million
1,292,376 New
1,292,376 $94.2 Million
Q4 2018

Feb 08, 2019
SELL
$62.67 - $88.33 $71 Million - $100 Million
-1,132,931 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$87.52 - $122.67 $99.2 Million - $139 Million
1,132,931 New
1,132,931 $99.2 Million
Q3 2018

Nov 09, 2018
SELL
$87.52 - $122.67 $71.6 Million - $100 Million
-818,236 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$88.31 - $107.8 $72.3 Million - $88.2 Million
818,236 New
818,236 $80.6 Million
Q2 2018

Jul 23, 2018
SELL
$88.31 - $107.8 $71 Million - $86.7 Million
-803,963 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$115.92 - $148.54 $93.2 Million - $119 Million
803,963 New
803,963 $95.8 Million
Q1 2018

May 09, 2018
SELL
$115.92 - $148.54 $86 Million - $110 Million
-742,261 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$114.49 - $139.98 $85 Million - $104 Million
742,261 New
742,261 $94.3 Million
Q4 2017

Feb 09, 2018
SELL
$114.49 - $139.98 $63.5 Million - $77.7 Million
-555,019 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$72.53 - $118.27 $40.3 Million - $65.6 Million
555,019 New
555,019 $65.2 Million
Q3 2017

Nov 07, 2017
SELL
$72.53 - $118.27 $54 Million - $88 Million
-744,415 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
100,000 Added 15.52%
744,415 $59.4 Million
Q1 2017

May 11, 2018
BUY
N/A
96,646 Added 17.64%
644,415 $33 Million
Q3 2016

Nov 13, 2017
BUY
N/A
547,769
547,769 $0

Others Institutions Holding ALNY

# of Institutions
645
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.22M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $32.8B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email